Sectors
PRQR
ProQR Therapeutics N.V.
2.13
1 x 2.17
2 x 2.76
bid
ask
-
0.16
6.99%
2 @ 04:00 PM
2.17 +0.04 (1.88%)
| Ytd | 5.45% | |
| 1y | -5.33% |
2.12
day range
2.29
1.33
52 week range
3.10
| Open | 2.26 | Prev Close | 2.29 | Low | 2.12 | High | 2.29 | Mkt Cap | 300.58M |
| Vol | 943.51K | Avg Vol | 1.11M | EPS | -0.47 | P/E | N/A | Forward P/E | -5.68 |
| Beta | 0.25 | Short Ratio | 0.31 | Inst. Own | 24.96% | Dividend | N/A | Div Yield | N/A |
| Ex Div Date | N/A | Earning | 11-05 | 50-d Avg | 1.88 | 200-d Avg | 1.79 | 1yr Est | 8.00 |
| Income Statement | |||
| Total Revenue | 8.76M | ||
| Revenues (USD) | 9.95M | ||
| Gross Profit | 8.76M | ||
| Operating Expenses | 17.58M | ||
| Research and Development Expense | 12.67M | ||
| Selling, General and Administrative Expense | 4.91M | ||
| Operating Income | -8.82M | ||
| Interest Expense | -152.00K | ||
| Income Tax Expense | 25.00K | ||
| Net Income | -8.73M | ||
| Net Income Common Stock | -8.73M | ||
| Net Income Common Stock (USD) | -9.92M | ||
| Consolidated Income | -8.73M | ||
| Earnings per Basic Share | -0.08 | ||
| Earnings per Basic Share (USD) | -0.09 | ||
| Earnings per Diluted Share | -0.08 | ||
| Earning Before Interest & Taxes (EBIT) | -8.85M | ||
| Earning Before Interest & Taxes (USD) | -10.06M | ||
| Weighted Average Shares | 109.96M | ||
| Weighted Average Shares Diluted | 109.96M | ||
| Balance Sheet | |||
| Cash and Equivalents | 117.13M | ||
| Cash and Equivalents (USD) | 133.10M | ||
| Trade and Non-Trade Receivables | 3.91M | ||
| Current Assets | 121.63M | ||
| Property, Plant & Equipment Net | 11.92M | ||
| Total Assets | 133.55M | ||
| Debt Current | 6.62M | ||
| Total Debt | 15.31M | ||
| Current Liabilities | 34.87M | ||
| Debt Non-Current | 8.69M | ||
| Total Liabilities | 54.08M | ||
| Shareholders Equity | 79.48M | ||
| Shareholders Equity (USD) | 90.31M | ||
| Assets Non-Current | 11.92M | ||
| Total Debt (USD) | 17.40M | ||
| Deferred Revenue | 28.15M | ||
| Liabilities Non-Current | 19.20M | ||
| Tax Assets | 597.00K | ||
| Tax Liabilities | 214.00K | ||
| Cash Flow | |||
| Depreciation, Amortization & Accretion | 707.00K | ||
| Net Cash Flow from Financing | 48.58M | ||
| Net Cash Flow / Change in Cash & Cash Equivalents | 36.02M | ||
| Capital Expenditure | -291.00K | ||
| Issuance (Purchase) of Equity Shares | 49.20M | ||
| Issuance (Repayment) of Debt Securities | -621.00K | ||
| Net Cash Flow from Investing | -291.00K | ||
| Net Cash Flow from Operations | -12.47M | ||
| Effect of Exchange Rate Changes on Cash | 18.00K | ||
| Share Based Compensation | 1.36M | ||